The New York Genome Center will purchase the Irys System from San Diego’s BioNano Genomics Inc., as part of what the companies call a strategic partnership. Financial terms of the deal were not disclosed.

The Irys equipment increases the ease of DNA sequencing, the company said, by detecting any variations in gene structure and allowing a researcher to complete genome assemblies.

“For BioNano, demonstrating the ability to deliver a commercial-ready technology that can address the long-range information needs of a premier genome center like NYGC marks an important milestone,” Todd Dickinson, vice president of global commercial operations for BioNano, said in a statement. “With their Irys System, the NYGC will now provide their direct research community with the most advanced long-read commercial technology to accelerate translational research and ultimately improve human health, consistent with the mission of this new center.”

BioNano is a privately funded company founded in 2006. Last year it raised about $33.5 million in Series B funding, but hasn’t announced any recent rounds since.

— SDBJ Staff Report